Home › Funds › LGL PARTNERS, LLC › WST
LGL PARTNERS, LLC position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
LGL PARTNERS, LLC reported holding 1,041 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$374K, representing 0.14% of its reported portfolio and ranking #46 among its reported holdings. LGL PARTNERS, LLC has disclosed WST holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How LGL PARTNERS, LLC's WST position evolved
LGL PARTNERS, LLC first disclosed a stake in WST in Q4 2024 at 651 shares (US$213K). The position peaked in Q2 2026 at 1,041 shares, worth US$374K. Across 7 filings, LGL PARTNERS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,041 shares valued at US$374K. Notable position changes include a 59% increase in Q1 2025 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 651 | $213.24K | New |
| Q1 2025 | 1.04K | $232.00K | Add |
| Q2 2025 | 1.04K | $249.73K | Hold |
| Q3 2025 | 1.04K | $272.36K | Hold |
| Q4 2025 | 1.04K | $285.90K | Hold |
| Q1 2026 | 1.04K | $260.68K | Hold |
| Q2 2026 | 1.04K | $373.65K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WST and 13F data
WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WST
- Artisan Partners Limited Partnership 2.41M sh · $865.83M · Q2 2026
- GENERATION INVESTMENT MANAGEMENT LLP 2.03M sh · $728.17M · Q2 2026
- BROWN ADVISORY INC 1.08M sh · $386.04M · Q2 2026
- Longview Partners (Guernsey) LTD 1.03M sh · $371.14M · Q2 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 760.62K sh · $273.06M · Q2 2026
- ProShare Advisors LLC 598.02K sh · $214.69M · Q2 2026
- Findlay Park Partners LLP 596.65K sh · $214.20M · Q2 2026
- Epoch Investment Partners, Inc. 562.56K sh · $201.96M · Q2 2026
- JACOBS LEVY EQUITY MANAGEMENT, INC 507.79K sh · $182.30M · Q2 2026
More on LGL PARTNERS, LLC
FAQ
How long has LGL PARTNERS, LLC held WST?
LGL PARTNERS, LLC has disclosed WST holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is LGL PARTNERS, LLC's current position in WST?
As of Q2 2026, LGL PARTNERS, LLC holds 1.04K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $373.65K, representing 0.14% of its reported portfolio and ranking #46.
Has LGL PARTNERS, LLC been buying or selling WST?
In the latest 13F filing (Q2 2026), LGL PARTNERS, LLC held unchanged its position in WST. The position peaked in Q2 2026 at 1.04K shares.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.